CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Brooklyn, NY
Black Nurses Association of Greater Houston 6436 Fannin St, Houston, TX, United StatesThis program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.